Increased cyclooxygenase-2 expression in peripheral blood mononuclear cells of smokers and hyperlipidemic subjects

Free Radical Biology and Medicine

Volumn 38, Issue 2, 2005, Pages 235-242

  Bonaterra, Gabriel A ^a   Hildebrandt, Wulf ^b   Bodens, Anne ^a   Sauer, Roland ^a   Dugi, Klaus A ^c   Deigner, Hans Peter ^d   Dröge, Wulf ^b   Metz, Jürgen ^a   Kinscherf, Ralf ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c NONE   (Germany)

^d SIRS Lab Jena   (Germany)

Author keywords

Free radicals; Hypercholesterolemia; Hyperlipoproteinemia; Inflammation; Risk factors; Smoking

Indexed keywords

CYCLOOXYGENASE 2; CYSTEINE; GLUTAMIC ACID; OXIDIZED LOW DENSITY LIPOPROTEIN; RNA;

ARTERIOSCLEROSIS; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERLIPOPROTEINEMIA; INFLAMMATION; MACROPHAGE; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SMOKING;

ADULT; AMINO ACIDS; BLOTTING, WESTERN; BODY MASS INDEX; CHOLESTEROL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOOXYGENASE 2; CYSTEINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; HYPERLIPIDEMIAS; INFLAMMATION; LEUKOCYTES, MONONUCLEAR; LIPOPROTEINS, LDL; MACROPHAGES; MALE; MEMBRANE PROTEINS; OXIDANTS; OXYGEN; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; REGRESSION ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK; RISK FACTORS; RNA; SMOKING;

EID: 10644259638     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2004.10.021     Document Type: Article

References (33)

1. N. Sattar, D.W. McCarey, H. Capell, and I.B. McInnes Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis Circulation 108 2003 2957 2963
2. M.F. Linton, and S. Fazio Cyclooxygenase-2 and inflammation in atherosclerosis Curr. Opin. Pharmacol. 4 2004 116 123
3. P.T. Kovanen, and M.O. Pentikainen Circulating lipoproteins as proinflammatory and anti-inflammatory particles in atherogenesis Curr. Opin. Lipidol. 14 2003 411 419
4. G. Block, C. Jensen, M. Dietrich, E.P. Norkus, M. Hudes, and L. Packer Plasma C-reactive protein concentrations in active and passive smokers: influence of antioxidant supplementation J. Am. Coll. Nutr. 23 2004 141 147
5. R. Kinscherf, K. Cafaltzis, F. Roder, W. Hildebrandt, L. Edler, H.P. Deigner, R. Breitkreutz, G. Feussner, J. Kreuzer, E. Werle, G. Michel, J. Metz, and W. Dröge Cholesterol levels linked to abnormal plasma thiol concentrations and thiol/disulfide redox status in hyperlipidemic subjects Free Radic. Biol. Med. 35 2003 1286 1292
6. Y.I. Miller, M.K. Chang, C.J. Binder, P.X. Shaw, and J.L. Witztum Oxidized low density lipoprotein and innate immune receptors Curr. Opin. Lipidol. 14 2003 437 445
7. A.V. Pontsler, A. St Hilair, G.K. Marathe, G.A. Zimmerman, and T.M. McIntyre Cyclooxygenase-2 is induced in monocytes by peroxisome proliferator activated receptor gamma and oxidized alkyl phospholipids from oxidized low density lipoprotein J. Biol. Chem. 277 2002 13029 13036
8. M.E. Burleigh, V.R. Babaev, J.A. Oates, R.C. Harris, S. Gautam, D. Riendeau, L.J. Marnett, J.D. Morrow, S. Fazio, and M.F. Linton Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice Circulation 105 2002 1816 1823
9. E. Wong, J.Q. Huang, P. Tagari, and D. Riendeau Effects of COX-2 inhibitors on aortic prostacyclin production in cholesterol-fed rabbits Atherosclerosis 157 2001 393 402
10. B.K. Hong, H.M. Kwon, B.K. Lee, D. Kim, I.J. Kim, S.M. Kang, Y. Jang, S.H. Cho, H.K. Kim, B.C. Jang, S.Y. Cho, H.S. Kim, M.S. Kim, H.C. Kwon, and N. Lee Coexpression of cyclooxygenase-2 and matrix metalloproteinases in human aortic atherosclerotic lesions Yonsei Med. J. 41 2000 82 88
11. C.S. Baker, R.J. Hall, T.J. Evans, A. Pomerance, J. Maclouf, C. Creminon, M.H. Yacoub, and J.M. Polak Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages Arterioscler. Thromb. Vasc. Biol. 19 1999 646 655
12. V. Stemme, J. Swedenborg, H. Claesson, and G.K. Hansson Expression of cyclo-oxygenase-2 in human atherosclerotic carotid arteries Eur. J. Vasc. Endovasc. Surg. 20 2000 146 152
13. F. Cipollone, M. Fazia, A. Iezzi, M. Zucchelli, B. Pini, D. De Cesare, S. Ucchino, F. Spigonardo, G. Bajocchi, R. Bei, R. Muraro, L. Artese, A. Piattelli, F. Chiarelli, F. Cuccurullo, and A. Mezzetti Suppression of the functionally coupled cyclooxygenase-2/prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans Circulation 107 2003 1479 1485
14. F. Cipollone, C. Prontera, B. Pini, M. Marini, M. Fazia, D. De Cesare, A. Iezzi, S. Ucchino, G. Boccoli, V. Saba, F. Chiarelli, F. Cuccurullo, and A. Mezzetti Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability Circulation 104 2001 921 927
15. H. Drexler, and B. Hornig Endothelial dysfunction in human disease J. Mol. Cell. Cardiol. 31 1999 51 60
16. J.A. Ardans, A.P. Economou, J.M. Martinson Jr., M. Zhou, and L.M. Wahl Oxidized low-density and high-density lipoproteins regulate the production of matrix metalloproteinase-1 and -9 by activated monocytes J. Leukocyte Biol. 71 2002 1012 1018
17. V. Hack, O. Stütz, R. Kinscherf, M. Schykowski, M. Kellerer, E. Holm, and W. Dröge Elevated venous glutamate levels in (pre)catabolic conditions result at least partly from a decreased glutamate transport activity J. Mol. Med. 74 1996 337 343
18. R. Kinscherf, V. Hack, T. Fischbach, B. Friedmann, C. Weiss, L. Edler, P. Bärtsch, and W. Dröge Low plasma glutamine in combination with high glutamate levels indicate risk for loss of body cell mass in healthy individuals: the effect of N-acetyl-cysteine J. Mol. Med. 74 1996 393 400
19. R. Kinscherf, R. Claus, M. Wagner, C. Gehrke, H. Kamencic, D. Hou, O. Nauen, W. Schmiedt, G. Kovacs, J. Pill, J. Metz, and H.P. Deigner Apoptosis caused by oxidized LDL is manganese superoxide dismutase and p53 dependent FASEB J. 12 1998 461 467
20. Y.H. Park, H.S. Ryu, D.S. Choi, K.H. Chang, D.W. Park, and C.K. Min Effects of hepatocyte growth factor on the expression of matrix metalloproteinases and their tissue inhibitors during the endometrial cancer invasion in a three-dimensional coculture Int. J. Gynecol. Cancer 13 2003 53 60
21. J. Norgauer, Y. Ibig, D. Gmeiner, Y. Herouy, and B.L. Fiebich Prostaglandin E2 synthesis in human monocyte-derived dendritic cells Int. J. Mol. Med. 12 2003 83 86
22. F. Zamamiri-Davis, Y. Lu, J.T. Thompson, K.S. Prabhu, P.V. Reddy, L.M. Sordillo, and C.C. Reddy Nuclear factor-kappaB mediates over-expression of cyclooxygenase-2 during activation of RAW 264.7 macrophages in selenium deficiency Free Radic. Biol. Med. 32 2002 890 897
23. C.H. Liao, S. Sang, Y.C. Liang, C.T. Ho, and J.K. Lin Suppression of inducible nitric oxide synthase and cyclooxygenase-2 in downregulating nuclear factor-kappa B pathway by Garcinol Mol. Carcinog. 41 2004 140 149
24. W. Hildebrandt, R. Kinscherf, K. Hauer, E. Holm, and W. Dröge Plasma cystine concentration and redox state in aging and physical exercise Mech. Ageing Dev. 123 2002 1269 1281
25. W. Dröge Cysteine and glutathione deficiency in AIDS patients: a rationale for the treatment with N-acetyl-cysteine Pharmacology 46 1993 61 65
26. W. Dröge, K.K. Murthy, C. Stahl-Hennig, S. Hartung, R. Plesker, S. Rouse, E. Peterhans, R. Kinscherf, T. Fischbach, and H.P. Eck Plasma amino acid dysregulation after lentiviral infection AIDS Res. Hum. Retroviruses 9 1993 807 809
27. W. Dröge Free radicals in the physiological control of cell function Physiol. Rev. 82 2002 47 95
28. M. Vayssier-Taussat, T. Camilli, Y. Aron, C. Meplan, P. Hainaut, B.S. Polla, and B. Weksler Effects of tobacco smoke and benzo[a]pyrene on human endothelial cell and monocyte stress responses Am. J. Physiol. Heart Circ. Physiol. 280 2001 H1293 1300
29. R. Chenevard, D. Hurlimann, M. Bechir, F. Enseleit, L. Spieker, M. Hermann, W. Riesen, S. Gay, R.E. Gay, M. Neidhart, B. Michel, T.F. Luscher, G. Noll, and F. Ruschitzka Selective COX-2 inhibition improves endothelial function in coronary artery disease Circulation 107 2003 405 409
30. M.A. Hernandez-Presa, J.L. Martin-Ventura, M. Ortego, A. Gomez-Hernandez, J. Tunon, P. Hernandez-Vargas, L.M. Blanco-Colio, S. Mas, C. Aparicio, L. Ortega, F. Vivanco, J.G. Gerique, C. Diaz, G. Hernandez, and J. Egido Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells Atherosclerosis 160 2002 49 58
31. A. Kalela, T.A. Koivu, M. Hoyhtya, O. Jaakkola, T. Lehtimaki, P. Sillanaukee, and S.T. Nikkari Association of serum MMP-9 with autoantibodies against oxidized LDL Atherosclerosis 160 2002 161 165
32. M.L. Brennan, and S.L. Hazen Emerging role of myeloperoxidase and oxidant stress markers in cardiovascular risk assessment Curr. Opin. Lipidol. 14 2003 353 359
33. G.P. O'Neill, and A.W. Ford-Hutchinson Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues FEBS Lett. 330 1993 156 160